SciTransfer
Organization

TALLERES AZUARA SL

Spanish SME producing Decolourised Hydrolysed Protein from animal blood via a proprietary EU-validated industrial processing plant.

Technology SMEfoodESSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
2
Total EC funding
€2.0M
Unique partners
0
What they do

Their core work

Talleres Azuara is a Spanish SME based in Valls (Tarragona) that develops and manufactures industrial processing equipment for the food and agri-food sector. Their documented H2020 work centers on building a proprietary processing plant to produce Decolourised Hydrolysed Protein (DHP) from animal blood — a high-value protein ingredient recovered from slaughterhouse byproducts. The company successfully progressed through the EU's competitive SME Instrument programme, winning both Phase 1 feasibility funding and a large Phase 2 innovation grant for the same technology, signalling strong commercial validation. Their background in mechanical workshops ("talleres") suggests in-house capability in custom equipment fabrication and process engineering.

Core expertise

What they specialise in

Decolourised Hydrolysed Protein (DHP) productionprimary
2 projects

Both HYDROBLOOD projects (Phase 1 and Phase 2) focus exclusively on developing an industrial plant for DHP production from animal blood.

Slaughterhouse byproduct valorisationprimary
2 projects

HYDROBLOOD targets the conversion of blood — a low-value slaughter byproduct — into a marketable food or feed protein ingredient, a core circular-economy application.

Industrial food processing plant engineeringprimary
2 projects

The HYDROBLOOD Phase 2 grant of ~€2M supports the development of a full processing plant, consistent with an engineering firm designing and building custom food-sector machinery.

SME innovation and scale-up managementsecondary
2 projects

Successfully coordinating both SME Instrument Phase 1 (feasibility) and Phase 2 (market-ready innovation) demonstrates capacity to manage EU-funded R&D from concept to pilot scale.

Evolution & trajectory

How they've shifted over time

Early focus
Blood protein processing feasibility
Recent focus
DHP plant scale-up and commercialisation

Talleres Azuara's entire H2020 record is a single technology trajectory: the HYDROBLOOD project pursued in two sequential phases between 2016 and 2019. Phase 1 (2016, €50,000) was a feasibility and business case study, while Phase 2 (2017–2019, ~€2M) moved into full development and pilot plant construction. There is no visible pivot or broadening — this organisation committed deeply to one specific innovation and followed it through the SME Instrument pipeline from idea to market-ready solution. The absence of subsequent H2020 projects suggests either that commercialisation of HYDROBLOOD became their primary focus after 2019, or that they did not pursue further EU funding once the technology was developed.

Their trajectory points toward a company that has completed its R&D phase and is now in commercial deployment of DHP production technology — a potential partner for licensing, joint ventures, or supply of processing equipment rather than for new research consortia.

Collaboration profile

How they like to work

Role: consortium_leaderReach: Local

Talleres Azuara operated exclusively as project coordinator across both H2020 projects, which for SME Instrument grants is standard — these are single-company innovation grants rather than multi-partner consortia. As a result, they show zero consortium partners in the H2020 record, meaning there is no evidence of their behaviour within multi-actor research teams. Any future collaboration would likely be their first experience working inside a larger EU consortium, which is worth factoring into partnership planning.

Talleres Azuara has no recorded consortium partners from their H2020 participation, as both projects were solo SME Instrument grants. Their network footprint within the EU research ecosystem is effectively a blank slate — there are no established co-applicant relationships to leverage.

Why partner with them

What sets them apart

Talleres Azuara holds a rare combination: hands-on manufacturing capability ("talleres") paired with a validated, EU-funded proprietary process for producing food-grade protein from slaughterhouse blood waste. Few companies in the Iberian agri-food equipment space have taken a byproduct valorisation technology all the way through the SME Instrument's Phase 1 + Phase 2 gauntlet, which implies a credible business case and a working pilot. For a consortium needing a specialist in animal-derived protein recovery or circular food chain processing, they offer both the engineering know-how and a proven technology asset.

Notable projects

Highlights from their portfolio

  • HYDROBLOOD
    Phase 2 grant of nearly €2M — one of the larger SME Instrument awards — validates the commercial potential of their proprietary DHP processing technology and marks them as a credible deep-tech SME in food protein recovery.
  • HYDROBLOOD
    The Phase 1 feasibility award (2016) confirmed market viability and directly unlocked the larger Phase 2 grant, demonstrating a disciplined innovation-to-market progression unusual for a small manufacturing workshop.
Cross-sector capabilities
Animal feed ingredients and circular bioeconomyIndustrial biotechnology and protein hydrolysisWaste valorisation and agri-food byproduct processing
Analysis note: Only two projects exist, both phases of the same initiative with no keywords recorded and no consortium partners. The profile is coherent but narrow — almost everything derives from the project title and description snippet. The company's broader manufacturing activities beyond HYDROBLOOD are not reflected in H2020 data.